Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of tear osmolarity and quality of life with unpreserved latanoprost 0.005%
2014-005379-10Phase 4Completed
- Sponsor
- Emiliano Hernández Galilea
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of latanoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Emiliano Hernández Galilea. Primary endpoint: Tear film osmolarity. Started Mar 2015; status: completed.
02
Drugs
latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2014-005379-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005379-10.